Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study
NCT ID: NCT01880203
Last Updated: 2016-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2013-05-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Diagnostic Value of Shear Wave Elastography
NCT02150772
The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules
NCT02937467
The Observer Variation of Shear Wave Elastography
NCT02022319
Utility of Contrast-Enhanced Sonography and Shear Wave Elastography
NCT04614389
Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters
NCT06207188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
aspiration for Molecular Cytogenetic Analysis.
aspiration in thyroid node for Molecular Cytogenetic Analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aspiration in thyroid node for Molecular Cytogenetic Analysis.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with thyroid nodules ≥ 15 mm with an indeterminate cytology (IC) older than 6 months, for which a surgical indication was raised
* vesicular lesion of undetermined significance
* follicular neoplasm or Hurthle cells
* lesion suspicious for malignancy
* Confirmation of indeterminate cytology (IC) replay centralized
* Patient affiliated to a social security scheme
* Informed consent and signed
Exclusion Criteria
* Nodules coalescing preventing proper individualization of targeted nodule
* Indeterminate cytology older than six months
* Nodules with indeterminate cytology not, ie non-diagnostic cytology, benign and malignant cytology cytology
* Major subject to a measure of legal protection or unable to consent
* Refusal to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation avenir
UNKNOWN
laboratoire Genzyme
UNKNOWN
Centre Francois Baclesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre François BACLESSE
Caen, Calvados, France
CHU
Caen, Calvados, France
Hôpital Américain de Paris
Neuilly-sur-Seine, , France
Hôpital Pitié-salpétrière
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bardet S, Goardon N, Lequesne J, Vaur D, Ciappuccini R, Leconte A, Monpeyssen H, Saguet-Rysanek V, Clarisse B, Lasne-Cardon A, Menegaux F, Leenhardt L, Buffet C. Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study. Endocrine. 2021 Feb;71(2):407-417. doi: 10.1007/s12020-020-02411-4. Epub 2020 Jul 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SWEETMAC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.